DE2304977A1 - 3-Aminoaryl-5-alkyl-4,5-dihydro-6(1H)-pyridazones - prepd. by reacting 2-alkyl-3-aminoaroyl-propionic acids with hydrazines - Google Patents
3-Aminoaryl-5-alkyl-4,5-dihydro-6(1H)-pyridazones - prepd. by reacting 2-alkyl-3-aminoaroyl-propionic acids with hydrazinesInfo
- Publication number
- DE2304977A1 DE2304977A1 DE19732304977 DE2304977A DE2304977A1 DE 2304977 A1 DE2304977 A1 DE 2304977A1 DE 19732304977 DE19732304977 DE 19732304977 DE 2304977 A DE2304977 A DE 2304977A DE 2304977 A1 DE2304977 A1 DE 2304977A1
- Authority
- DE
- Germany
- Prior art keywords
- methyl
- dihydropyridazinone
- formula
- hydrogen
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000002429 hydrazines Chemical class 0.000 title description 4
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 6
- -1 acyl radical Chemical group 0.000 claims description 77
- 150000001875 compounds Chemical class 0.000 claims description 20
- 125000004432 carbon atom Chemical group C* 0.000 claims description 18
- 229910052739 hydrogen Inorganic materials 0.000 claims description 11
- 239000001257 hydrogen Substances 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 11
- 125000003277 amino group Chemical group 0.000 claims description 10
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 10
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical group NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims description 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
- 229920006395 saturated elastomer Polymers 0.000 claims description 7
- 229910052736 halogen Inorganic materials 0.000 claims description 6
- SSDAKJLEKSSAMH-UHFFFAOYSA-N 2,4-dihydro-1h-pyridazin-3-one Chemical compound O=C1CC=CNN1 SSDAKJLEKSSAMH-UHFFFAOYSA-N 0.000 claims description 5
- 150000002367 halogens Chemical class 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 150000001412 amines Chemical class 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 125000002252 acyl group Chemical group 0.000 abstract description 4
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 2
- 125000005843 halogen group Chemical group 0.000 abstract description 2
- 125000000266 alpha-aminoacyl group Chemical group 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000001741 anti-phlogistic effect Effects 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 238000002844 melting Methods 0.000 description 14
- 230000008018 melting Effects 0.000 description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- 238000009835 boiling Methods 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- FZERHIULMFGESH-UHFFFAOYSA-N N-phenylacetamide Chemical compound CC(=O)NC1=CC=CC=C1 FZERHIULMFGESH-UHFFFAOYSA-N 0.000 description 4
- 150000001735 carboxylic acids Chemical class 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- IYVMXBHPHVDPNJ-UHFFFAOYSA-N 4-(4-aminophenyl)-2-methyl-4-oxobutanoic acid Chemical compound OC(=O)C(C)CC(=O)C1=CC=C(N)C=C1 IYVMXBHPHVDPNJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000005457 ice water Substances 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 125000001424 substituent group Chemical group 0.000 description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 description 2
- DFATXMYLKPCSCX-UHFFFAOYSA-N 3-methylsuccinic anhydride Chemical compound CC1CC(=O)OC1=O DFATXMYLKPCSCX-UHFFFAOYSA-N 0.000 description 2
- FPLBBTORMLFWEY-UHFFFAOYSA-N 4-(4-acetamidophenyl)-2-methyl-4-oxobutanoic acid Chemical compound OC(=O)C(C)CC(=O)C1=CC=C(NC(C)=O)C=C1 FPLBBTORMLFWEY-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229960001413 acetanilide Drugs 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 150000001244 carboxylic acid anhydrides Chemical class 0.000 description 2
- 150000001733 carboxylic acid esters Chemical class 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
- 239000012433 hydrogen halide Substances 0.000 description 2
- 229910000039 hydrogen halide Inorganic materials 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 description 1
- 125000006325 2-propenyl amino group Chemical group [H]C([H])=C([H])C([H])([H])N([H])* 0.000 description 1
- KLKFUQVAHJKMCI-UHFFFAOYSA-N 3-(4-aminophenyl)-2-methyl-3-oxopropanoic acid Chemical compound NC1=CC=C(C(=O)C(C(=O)O)C)C=C1 KLKFUQVAHJKMCI-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 238000005727 Friedel-Crafts reaction Methods 0.000 description 1
- 229910003204 NH2 Inorganic materials 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 125000000440 benzylamino group Chemical group [H]N(*)C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 125000002668 chloroacetyl group Chemical group ClCC(=O)* 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000004663 dialkyl amino group Chemical group 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 1
- WHQSYGRFZMUQGQ-UHFFFAOYSA-N n,n-dimethylformamide;hydrate Chemical compound O.CN(C)C=O WHQSYGRFZMUQGQ-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 150000003141 primary amines Chemical class 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- BHRZNVHARXXAHW-UHFFFAOYSA-N sec-butylamine Chemical compound CCC(C)N BHRZNVHARXXAHW-UHFFFAOYSA-N 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
Description
Neue Dihydropyridazinone Die Erfindung betrifft Dihydropyridazinone der Formel I deren Säureadditionssalze und Verfahren zu ihrer Herstellung.New Dihydropyridazinones The invention relates to dihydropyridazinones of the formula I. their acid addition salts and processes for their preparation.
In der Formel I haben die einzelnen Reste folgende Bedeutung: R1 niedriges Alkyl, R2 Wasserstoff oder niedriges Alkyl und R3 ein Wasserstoffatom oder einen Acylrest.In the formula I, the individual radicals have the following meanings: R1 is lower Alkyl, R2 is hydrogen or lower alkyl and R3 is a hydrogen atom or a Acyl residue.
Für R1 und R2 sind als niedrige Alkylreste gesåttigtegeradkettige oder verzweigte Alkylreste mit 1 bis 6 C-Atomen zweckmäßig.For R1 and R2, the lower alkyl radicals are saturated straight-chain or branched alkyl radicals having 1 to 6 carbon atoms are expedient.
Davon sind beispielsweise zu nennen: Methyl, Äthyl, Isopropyl,Propyl, Butyl, Amyl und Isoamyl Die besonders bevorzugten Alkylreste für R1 sind Methyl und Propyl. Der besonders bevorzugte Alkylrest für R2 is Methyl.Examples of these are: methyl, ethyl, isopropyl, propyl, Butyl, Amyl and Isoamyl The particularly preferred alkyl radicals for R1 are methyl and propyl. The particularly preferred alkyl radical for R2 is methyl.
Als Acylreste für R5 kommen in Betracht Acylreste gesättigter aliphatischer geradkettiger oder verzweigter Carbonsäuren mit 1 bis 7 C-Atomen, die gegebenenfalls substituiert sein können, oder cycloaliphatischer Carbonsäuren mit 5 bis 7 C-Atomen im Ring.Suitable acyl radicals for R5 are acyl radicals of saturated aliphatic straight-chain or branched carboxylic acids with 1 to 7 carbon atoms, which optionally can be substituted, or cycloaliphatic carboxylic acids with 5 to 7 carbon atoms in the ring.
Beispiele für Acylreste sind: Formyl, Carbäthoxy, Acetyl, Propionyl, Butyroyl, Valeroyl, Caproyl, Hexahydrobenzoyl.Examples of acyl radicals are: formyl, carbethoxy, acetyl, propionyl, Butyroyl, valeroyl, caproyl, hexahydrobenzoyl.
Die Acylreste können zusätzlich substituiert sein, wobei als Substituenten Halogen, wie Chlor, Brom, oder NH2, Alkylamino, Dialkylamino, cycloaliphatische Aminogruppen oder Amine, in denen der Aminstickstoff Teil eines gesättigten heterocyclischen Ringes ist, hervorzuheben sind.The acyl radicals can additionally be substituted, with as substituents Halogen, such as chlorine, bromine, or NH2, alkylamino, dialkylamino, cycloaliphatic Amino groups or amines in which the amine nitrogen is part of a saturated heterocyclic Ring is to be highlighted.
in den Aminogruppen Die AlkylresteXkönnen auch Doppelbindungen oder Dreifaehbindungen oder zusätzlich Phenylreste enthalten. Die Aminogruppen können sich ableiten von cyclischen Aminen, die weitere Heteroatome, wie Sauerstoff, Stickstoff oder Schwefel, im Ring enthalten. in the amino groups The alkyl radicals X can also contain double bonds or Triple bonds or additionally contain phenyl radicals. The amino groups can are derived from cyclic amines, which contain further heteroatoms, such as oxygen, nitrogen or sulfur, contained in the ring.
Beispiele für Aminogruppen als Substituenten der Acylreste sind.Examples of amino groups as substituents on the acyl radicals are.
Methylamino, Athylamino, n-Propylamino, Isopropylamino, sek.Methylamino, ethylamino, n-propylamino, isopropylamino, sec.
Butylamino, Cyclohexylamino, Cyclopentylamino, 2-thylphenylamino, Benzylamino, ß Hydroxyäthylamino, Allylamino, Butin-(1 )-yl-)-amino, Dimethylamino, Diäthylamino, Pyrrolidino, Piperidino, Morpholino, Hexamethylenimino, NMethylpiperazino.Butylamino, cyclohexylamino, cyclopentylamino, 2-thylphenylamino, Benzylamino, ß Hydroxyäthylamino, Allylamino, Butyn- (1) -yl -) - amino, Dimethylamino, Diethylamino, pyrrolidino, piperidino, morpholino, hexamethyleneimino, N-methylpiperazino.
Als Acylreste RS, die Halogen enthalten, seien genannt: Chloracetyl, Chlorpropionyl, Chlorbutyryl, .Bromvaleroyl.As acyl radicals RS that contain halogen, the following may be mentioned: chloroacetyl, Chloropropionyl, chlorobutyryl, bromovaleroyl.
Die bevorzugten Acylaminoreste leiten sich von der Essigsäure, Propionsäure, Valeriansäure ab und sind gegebenenfalls substituiert.The preferred acylamino radicals are derived from acetic acid, propionic acid, Valeric acid from and are optionally substituted.
Die erfindungsgemäßen Verbindungen besitzen in 4-Stellung des Dihydropyridazinonringes ein asymmetrisches C-Atom und können dadurch in stereoisomeren Formen vorliegen. Die Stereoisomeren oder ihre-Racemate werden von der Erfindung ausdrücklich miteingeschlossen.The compounds according to the invention have the 4-position of the dihydropyridazinone ring an asymmetric carbon atom and can therefore exist in stereoisomeric forms. The stereoisomers or their racemates are expressly included in the invention.
Als Beispiel für erfindungsgemäße Verbindungen seien aufgeführt: 6-(p-Aminophenyl)°4-methyl-4,5-dShydropyridazinon-(3) 6-(p-Formylaminophenyl)-4-methyl-4,5-dShydropyridazinon-(3) 6- (p-Carbäthoxyaminophenyl)4-meth l-4,5-dihydropyridazinon-(5) 6-(p-Acetarninophenyl) -6-(p-Hexahydrobenzoylaminophenyl)- " 6- (p-Chloracetaminophenyl ) -6-(p-ocPChlorpropionylaminophenyl)-6-(p-#-Bromvaleroylaminophenyl)- " 6-(p-Äthylaminoacetylaminophenyl)- " 6-(p-n-Propylaminoacetylaminophenyl)-4-methyl-4,5-dihydropyridazinon-(3) 6-(p-Isopropylaminoacetylaminophenyl)-4-methyl-4,5-dihydropyri dazinon-(3) 6-(p-sek.-Butylaminoacetylaminophenyl)-4-methyl-4,5-dihydropyridazinon-(3) 6-(p-Cyclohexylaminoacetylaminophenyl)-4-methyl-4,5-dihydropyridazinon-(3) 6-(p-ß-Hydroxyäthylaminoacetylaminophenyl)-4-methyl-4,5-dihydropyridazinon- (5) 6-(p-Allylaminoacetylaminophenyl)-4-methyl-4,5-dihydropyrida zinon- (5) 6-(p-Butin-(1)-yl-(3)-aminoacetylaminophenyl)-4-methyl-4,5-dihydropyridazinon-(3) 6-(p-2-Phenyläthylaminoacetylaminophenyl)-4-methyl-4,5-dihydropyridazinon-(3) 6- (p-Dimethylaminoacetylaminophenyl)-4-methyl-4,5-dihydropyri dazinon-(3) 6-(p-Diäthylaminoacetylaminophenyl)-4-methyl-4,5-dihydropyrida zinon-(3) 6- (p-Pyrrolidinoacetylaminophenyl)-4-methyl-4,5-dihydropyridazinon-(3) 6-(p-Morpholinoacetylaminophenyl)-4-methyl-4,5-dihydropyridazinon-(3) 6-(p-Hexamethyleniminoacetylaminophenyl)-4-methyl-4,5-dihydro pyridazinon- (5) 6-(p-N'-Mthylpiperazinoacetylaminoheny pyridazinon-(3) 6-(p-Aminophenyl)-2,4-dimethyl 4,5-dthydro-3(2H)pyridazinon 6-(p-Acetaminophenyl)-4-propyl-4,5-dihydro-3(2H)pyridazinon 6-(p-Aminophenyl)-4-propyl 4,5-dthydro-3(2H)pyridazinonO Die neuen Verbindungen können erhalten werden, indem man Acylanilide der Formel II mit einem 2-Alkylbernsteinsäureanhydrid der Formel III unter den Bedingungen einer Friedel-Crafts-Reaktion zum entsprechenden 2-Alkyl-3-(p-Acylaminobenzoyl)-propionsäure-Derivat der Formel IV umsetzt. Examples of compounds according to the invention include: 6- (p-aminophenyl) ° 4-methyl-4,5-d-hydropyridazinone- (3) 6- (p-formylaminophenyl) -4-methyl-4,5-d-hydropyridazinone- (3) 6- (p-Carbethoxyaminophenyl) 4-meth l-4,5-dihydropyridazinone- (5) 6- (p-acetaminophenyl) -6- (p-hexahydrobenzoylaminophenyl) - "6- (p-chloroacetaminophenyl) -6- (p -ocPchloropropionylaminophenyl) -6- (p - # - Bromvaleroylaminophenyl) - "6- (p-Ethylaminoacetylaminophenyl) -" 6- (pn-Propylaminoacetylaminophenyl) -4-methyl-4,5-dihydropyridazinone- (3) 6- (p- Isopropylaminoacetylaminophenyl) -4-methyl-4,5-dihydropyridazinone- (3) 6- (p-sec-Butylaminoacetylaminophenyl) -4-methyl-4,5-dihydropyridazinone- (3) 6- (p -cyclohexylaminoacetylaminophenyl) -4 -methyl-4,5-dihydropyridazinone- (3) 6- (p-β-hydroxyethylaminoacetylaminophenyl) -4-methyl-4,5-dihydropyridazinone- (5) 6- (p-allylaminoacetylaminophenyl) -4-methyl-4,5 -dihydropyrida zinon- (5) 6- (p-butyn- (1) -yl- (3) -aminoacetylaminophenyl) -4-methyl-4,5-dihydropyridazinone- (3) 6- (p-2-phenylethylaminoacety laminophenyl) -4-methyl-4,5-dihydropyridazinone- (3) 6- (p-dimethylaminoacetylaminophenyl) -4-methyl-4,5-dihydropyridazinone- (3) 6- (p-diethylaminoacetylaminophenyl) -4-methyl- 4,5-dihydropyridazinone- (3) 6- (p-pyrrolidinoacetylaminophenyl) -4-methyl-4,5-dihydropyridazinone- (3) 6- (p-morpholinoacetylaminophenyl) -4-methyl-4,5-dihydropyridazinone- ( 3) 6- (p-Hexamethyleneiminoacetylaminophenyl) -4-methyl-4,5-dihydro pyridazinone- (5) 6- (p-N'-Mthylpiperazinoacetylaminoheny pyridazinone- (3) 6- (p-aminophenyl) -2,4- dimethyl 4,5-dthydro-3 (2H) pyridazinone 6- (p-acetaminophenyl) -4-propyl-4,5-dihydro-3 (2H) pyridazinone 6- (p-aminophenyl) -4-propyl 4,5- dthydro-3 (2H) pyridazinonO The new compounds can be obtained by converting acylanilides of the formula II with a 2-alkylsuccinic anhydride of the formula III under the conditions of a Friedel-Crafts reaction to give the corresponding 2-alkyl-3- (p-acylaminobenzoyl) -propionic acid derivative of the formula IV.
In dem angegebenen Formelschema haben R1 die oben angegebene Bedeutung und R3 die Bedeutung eines Acylrestes einer gesättigten geradkettigen oder verzweigten, gegebenenfalls durch Halogen substituierten Carbonsäure mit 1 bis 7 C-Atomen oder einer cycloaliphatischen Carbonsäure mit 5 bis 7 C-Atomen im Ring.In the formula scheme given, R1 have the meaning given above and R3 is an acyl radical of a saturated straight-chain or branched one, Carboxylic acid with 1 to 7 carbon atoms which is optionally substituted by halogen or a cycloaliphatic carboxylic acid with 5 to 7 carbon atoms in the ring.
Beispielsweise wird bei Verwendung von Acetanilid (R3 = CH3-CO-) und Methylbernsteinsäureanhydrid (R1 = CH3) entsprechend der Formel IV 2-Methyl-3-(p-acetaminobenzoyl)-propionsäure gewonnen. For example, when using acetanilide (R3 = CH3-CO-) and methylsuccinic anhydride (R1 = CH3) according to the formula IV, 2-methyl-3- (p-acetaminobenzoyl) propionic acid is obtained.
Die Stellung der Methylgruppe läßt sich dabei durch das Massenspektrum beweisen.The position of the methyl group can be determined from the mass spectrum prove.
Die Verbindungen der Formel IV können mit Hydrazinen der Formel R2NHNH2J in der R2 die für die Verbindungen der Formel I angegebene Bedeutung hat, zu den Dihydropyridazinonen der Formel Ia in an sich bekannter Weise cyclisiert werden, in denen R3 den Acylrest einer gesättigten geradkettigen oder verzweigten, gegebenenfalls durch Halogen substituierten Carbonsäure mit 1 bis 7 C-Atomen oder einer cycloaliphatischen Carbonsäure mit 5 bis 7 C-Atomen im Ring bedeutet.The compounds of the formula IV can be combined with hydrazines of the formula R2NHNH2J, in which R2 has the meaning given for the compounds of the formula I, to give the dihydropyridazinones of the formula Ia in a manner known per se are cyclized in which R3 is the acyl radical of a saturated straight-chain or branched, optionally halogen-substituted carboxylic acid with 1 to 7 carbon atoms or a cycloaliphatic carboxylic acid with 5 to 7 carbon atoms in the ring.
Die Hydrolyse von Verbindungen der Formel IV nach an sich üblichen Methoden, beispielsweise mit wäßriger Salzsäure, ergibt 2-Alkyl-)-(p-aminobenzoyl)-propionsäuren der Formel V, die entsprechend folgender Gleichung mit Hydrazinen der Formel R2NHNH 2 zu Dihydropyridazinonen der Formel Ib mit unsubstituierter Aminogruppe cyclisiert werden können, wobei R1 und R2 die oben angegebenen Bedeutungen haben. The hydrolysis of compounds of the formula IV by conventional methods, for example with aqueous hydrochloric acid, gives 2-alkyl -) - (p-aminobenzoyl) propionic acids of the formula V, which according to the following equation with hydrazines of the formula R2NHNH 2 to dihydropyridazinones of the formula Ib can be cyclized with an unsubstituted amino group, where R1 and R2 have the meanings given above.
Die Dihydropyridazinone der Formel Ib können an der Aminogruppe auch nachträglich mit den entsprechenden Acylierungsmitteln, wie Carbonsäuren, Carbonsäureanhydriden, Garbonsäurechloriden, Carbonsäureestern oder den entsprechenden, durch Halogen substituierten funktionellen Säurederivaten acyliert werden zu Verbindungen der Formel Ia.The dihydropyridazinones of the formula Ib can also be attached to the amino group subsequently with the appropriate acylating agents, such as carboxylic acids, carboxylic acid anhydrides, Carboxylic acid chlorides, carboxylic acid esters or the corresponding substituted by halogen functional acid derivatives are acylated to give compounds of the formula Ia.
Dihydropyridazinone, in denen der Acylrest R3 einen durch Halogen substituierten Acylrest mit 1 bis 7 C-Atomen bedeutet, können mit primären oder sekundären Aminen der Formel umgesetzt werden, wobei durch eine Austauschreaktion die entsprechenden, im Acylrest durch Aminogruppen substituierten Dihydropyridazinone der Formel Ic entstehen. Dabei bedeuten R4 und R5 Wasserstoff oder geradkettige oder verzweigte Alkylreste bis zu 6 C-Atomen, die noch weitere Substituenten oder Doppelbindungen und Dreifachbindungen enthalten können. Rß und R5 können auch zusammen mit dem sie verbindenden Stickstoffatom, gegebenenfalls unter Beteiligung weiterer Heteroatome, wie Stickstoff, Sauerstoff, Schwefel, einen heterocyclischen Ring bilden. Dihydropyridazinones in which the acyl radical R3 is a halogen-substituted acyl radical having 1 to 7 carbon atoms can be mixed with primary or secondary amines of the formula are reacted, with an exchange reaction forming the corresponding dihydropyridazinones of the formula Ic which are substituted in the acyl radical by amino groups. R4 and R5 are hydrogen or straight-chain or branched alkyl radicals up to 6 carbon atoms, which can also contain further substituents or double bonds and triple bonds. R3 and R5 can also form a heterocyclic ring together with the nitrogen atom connecting them, optionally with the participation of further heteroatoms, such as nitrogen, oxygen, sulfur.
In den Verbindungen der Formel Ic haben R1, R2, R4 und R5 die angegebenen Bedeutungen, wobei C nH2n einen gesättigten geradkettigen oder verzweigten Alkylenrest mit 1 bis 6 C-Atomen bedeutet.In the compounds of the formula Ic, R1, R2, R4 and R5 are as indicated Meanings, where C nH2n is a saturated straight-chain or branched alkylene radical with 1 to 6 carbon atoms means.
Im folgenden sind allgemeine Reaktionsbedingungen der zu den erfindungsgemäßen Verbindungen führenden Verfahrensschritte näher erläutert: Verbindungen ergibt Ibo In der Regel erfolgt die Cyclisierung der Verbindungen der Formel IV bzw. V zu Dihydropyridazinonen der Formel Ia bzw. Ib mit der 1- bis 6-fachen Menge des entsprechenden Hydrazins der Formel R2NHNH oder unter Verwendung der entsprechenden Menge eines 2 Hydraziniumsalzes in einem unter den Reaktionsbedingungen inerten Lösungsmittel, beispielsweise Wasser, Methanol, Athanol, Isopropanol, Dioxan, Glykol, Dimethyläther, Dimethylformamid, bei Temperaturen etwa von 60 bis 1500C, vorzugsweise von 80 bis 1200C.General reaction conditions of the process steps leading to the compounds according to the invention are explained in more detail below: Compounds results in Ibo As a rule, the compounds of the formula IV or V are cyclized to dihydropyridazinones of the formula Ia or Ib with 1 to 6 times the amount of the corresponding hydrazine of the formula R2NHNH or using the corresponding amount of a 2 hydrazinium salt in one Solvents which are inert under the reaction conditions, for example water, methanol, ethanol, isopropanol, dioxane, glycol, dimethyl ether, dimethylformamide, at temperatures from about 60 to 150.degree. C., preferably from 80 to 1200.degree.
Verbindungen Die Acylierung von Dihydropyridazinonen der Formel Ib zu Dihydropyridazinonen der Formel Ia mit Carbonsäuren, Carbonsäureanhydriden, Carbonsäureestern, Carbonsäurechloriden kann ausgeführt werden unter Verwendung von mindestens einem Mol des Acylierungsmittels mit oder ohne Lösungsmittel, mit oder ohne Hilfsbase bei Temperaturen zwischen 0°C und den Siedetemperaturen des verwendeten Acylierungsmittels bzw Lösungsmittels, gegebenenfalls unter Anwendung von Druck.links The acylation of dihydropyridazinones of the formula Ib to dihydropyridazinones of the formula Ia with carboxylic acids, carboxylic acid anhydrides, carboxylic acid esters, carboxylic acid chlorides can be carried out using at least one mole of the acylating agent with or without a solvent, with or without an auxiliary base at temperatures between 0 ° C and the boiling temperatures of the acylating agent or solvent used, if appropriate with the application of pressure.
Verbindungen Die Umsetzungen der Verbindungen der allgemeinen Formel la zu Ic werden in Anwesenheit eines Halogenwasserstoff bindenden Mittels ausgeführt. Man arbeitet vorteilhaft in Gegenwart eines inerten organischen Lösungsmittels bei Temperaturen zwischen 50 und 15000 Als Halogenwasserstoff bind endes Mittel kann eine anorganische oder organische Base verwendet werden. Es eignet sich aber auch ein mindestens molarer Überschuß des entsprechenden Amins, das auch als Lösungsmittel dienen kann Weitere Wege für die Herstellung von Dihydropyridazinonen der Formel 1 können dem folgenden Schema entnommen werden: In dem Formelschema haben die Substituenten R1 bis R5 und (CnH2n) die angegebenen Bedeutungen. Ausgangsverbindung ist ein Ester, zweckmäßig sind niedere Alkylester, einer Verbindung der Formel V, die an der aromatischen Aminogruppe acyliert wird durch ein funktionelles Carbonsäurederivat RSY, wobei für Y Cl, OH, NOCH5, OC2H5 oder OR3 stehen kann, anschließend wird cyclisiert mit Hydrazin oder einem Hydrazinderivat zu den Verbindungen Ia. Wenn R3 ein durch Halogen substituierter Acylrest ist, kann das Halogenatom auch vor der Cyclisierung zum Dihydropyridazinon Ic durch eine Aminogruppe ausgetauscht werden. Bei dem angegebenen Formelschema kann in der Ausgangsverbindung für R auch Wasserstoff stehen.links The reactions of the compounds of the general formula la to Ic are carried out in the presence of an agent which binds hydrogen halide. It is advantageous to work in the presence of an inert organic solvent at temperatures between 50 and 15,000. An inorganic or organic base can be used as an agent which binds hydrogen halide. However, an at least molar excess of the corresponding amine, which can also serve as a solvent, is also suitable. Further routes for the preparation of dihydropyridazinones of the formula 1 can be found in the following scheme: In the formula scheme, the substituents R1 to R5 and (CnH2n) have the meanings given. The starting compound is an ester, lower alkyl esters, a compound of the formula V which is acylated on the aromatic amino group by a functional carboxylic acid derivative RSY, where Y can be Cl, OH, NOCH5, OC2H5 or OR3, is then cyclized with hydrazine or a hydrazine derivative to the compounds Ia. If R3 is an acyl radical substituted by halogen, the halogen atom can also be exchanged for an amino group before the cyclization to the dihydropyridazinone Ic. In the formula scheme given, R can also be hydrogen in the starting compound.
Die Verbindungen der Formel I können gegebenenfalls auf an sich bekannte Weise mit physiologisch verträglichen anorganischen oder organischen Säuren in Säureadditionssalze übergeführt werden. Als solche kommen beispielsweise Salzsäure, Schwefelsäure, Phosphorsäure, Essigsäure, Zitronensäure, Weinsäure, Maleinsäure, Fumarsäure oder Apfelsäure in Betracht.The compounds of the formula I can, if appropriate, be known per se Way with physiologically compatible inorganic or organic acids in acid addition salts be transferred. As such, for example, hydrochloric acid, sulfuric acid, phosphoric acid, Acetic acid, citric acid, tartaric acid, maleic acid, fumaric acid or malic acid in Consideration.
Die Verbindungen dieser Erfindung haben wertvolle pharmazeutische Eigenschaften, insbesondere sind beispielsweise cardiovasculäre und antiphlogistische Eigenschaften hervorzuheben.The compounds of this invention have valuable pharmaceutical properties Properties, in particular, are, for example, cardiovascular and anti-inflammatory Features to highlight.
Als besonders hervorzuhebende Verbindungen sind beispielsweise zu nennen: 6-(p-Aminophenyl)-4-methyl-4,5-dShydropyridazinon-(3), 6-(p-Formylaminophenyl)-4-methyl-4,5-dShydropyridazinonu 6-(p-Acetaminophenyl)-4-methyl-4,5-dShydropyridazinon Zubereitungen mit den neuen Verbindungen als Wirkstoff können nach dem Fachmann an sich bekannten Methoden entsprechend der gewünschten Applikationsart erhalten werden.Particularly noteworthy connections are, for example, to name: 6- (p-aminophenyl) -4-methyl-4,5-d-hydropyridazinone- (3), 6- (p-formylaminophenyl) -4-methyl-4,5-d-hydropyridazinone u 6- (p-Acetaminophenyl) -4-methyl-4,5-dShydropyridazinone preparations with the new Compounds as active ingredients can be prepared according to methods known per se to the person skilled in the art the desired type of application can be obtained.
Die folgenden Beispiele beschreiben die Herstellung von Ausgangsverbindungen und die Herstellung erfindungsgemäßer Verbindungen.The following examples describe the preparation of starting compounds and the preparation of compounds of the invention.
Beispiel 1 2-Methyl-)-(p-acetylaminobenzoyl)-propionsäureo Zu 1,2 kg wasserfreiem Aluminiumchlorid werden innerhalb von 50 Minuten 180 ml Dimethylformamid zugetropft, wobei eine stark exotherme Reaktion eintritt. Man trägt dann innerhalb von 10 Minuten 155 g (1 Mol) Acetanilid bei 60 bis 650C ein. Anschließend werden innerhalb von 25 Minuten bei der gleichen Temperatur 114 g (1 Mol) 2-Methylbernsteinsäureanhydrid zugetropft. Man erwärmt innerhalb eines Zeitraumes von 25 Minuten auf 70°C, rührt anschließend 1,5 Stunden bei dieser Temperatur und trägt die Schmelze dann in 6 kg Eis ein. Die Mischung wird mit 600 ml Salzsäure versetzt, es wird abgesaugt, mit Eiswasser neutral gewaschen und im Vakuum bei 100°C getrocknet. Die Rohausbeute beträgt 187 g (75 % der Theorie). Die Umkristallisation aus 2,7 1 ergibt 99,5 g (40 ß der Theorie) vom Schmelzpunkt 205 bis 2060C. Example 1 2-methyl -) - (p-acetylaminobenzoyl) -propionic acid To 1,2 kg of anhydrous aluminum chloride are 180 ml of dimethylformamide within 50 minutes added dropwise, with a strongly exothermic reaction occurs. One then carries within for 10 minutes 155 g (1 mol) of acetanilide at 60 to 650C. Then be 114 g (1 mol) of 2-methylsuccinic anhydride within 25 minutes at the same temperature added dropwise. The mixture is heated to 70 ° C. over a period of 25 minutes and stirred afterward 1.5 hours at this temperature and carries the melt then put in 6 kg of ice. The mixture is mixed with 600 ml of hydrochloric acid, it is suctioned off, washed neutral with ice water and dried in vacuo at 100.degree. The raw booty is 187 g (75% of theory). Recrystallization from 2.7 liters gives 99.5 g (40 ß of theory) from the melting point 205 to 2060C.
Beispiel 2 2-Methyl-)-(p-aminobenzoylp propionsäure: 84,7 g (0,)4 Mol) 3-(p-Aminobenzoyl)-2-methylpropionsäure werden in 250 ml Salzsäure 50 Minuten zum Sieden erhitzt. Anschließend wird bei 0 bis 50C mit Natriumcarbonatlösung auf pH 5 eingestellt, es wird abgesaugt, mit Eiswasser gewaschen und im Vakuum bei 1000C getrocknet. Die Ausbeute beträgt 65 g (71 ß der Theorie) vom Schmelzpunkt 150 bis 1510C. Example 2 2-methyl -) - (p-aminobenzoyl-propionic acid: 84.7 g (0.4) Mol) 3- (p-aminobenzoyl) -2-methylpropionic acid are in 250 ml hydrochloric acid for 50 minutes heated to boiling. Then at 0 to 50C with sodium carbonate solution The pH is adjusted to 5, it is filtered off with suction, washed with ice water and in vacuo at 1000C dried. The yield is 65 g (71 ß of theory) with a melting point of 150 to 1510C.
Beispiel 3 6-(p-Acetaminophenyl)-4-methyl-4,5-dihydropyridazinon-3: 5 g (0,02 Mol) 3-(p-Acetaminobenzoyl)-2-methylpropionsäure werden in 50 ml Wasser mit 1,25 g (0,025 Mol) Hydrazinhydrat 3 Stunden zum Sieden erhitzt. Nach dem Abkühlen wird bei OOC abgesaugt, mit Eiswasser gewaschen und im Vakuum bei 1000C getrocknet. Example 3 6- (p-Acetaminophenyl) -4-methyl-4,5-dihydropyridazinon-3: 5 g (0.02 mol) of 3- (p-acetaminobenzoyl) -2-methylpropionic acid are dissolved in 50 ml of water heated to boiling with 1.25 g (0.025 mol) of hydrazine hydrate for 3 hours. After cooling down is suctioned off at OOC, washed with ice water and dried in vacuo at 1000C.
Ausbeute: 4,7 g (96 % der Theorie), Schmelzpunkt 214 bis 2150C (aus Athanol).Yield: 4.7 g (96% of theory), melting point 214 to 2150C (from Ethanol).
In entsprechender Weise wird aus 3-(p-Acetaminobenzoyl)-2-propylpropionsäure 6-(p-Acetaminophenyl)-4-propyl-4,5-dihydropyridazinon-5 vom Schmelzpunkt 158 bis 160°C gewonnen.In a corresponding manner, 3- (p-acetaminobenzoyl) -2-propylpropionic acid is converted 6- (p-Acetaminophenyl) -4-propyl-4,5-dihydropyridazinone-5 from melting point 158 to 160 ° C obtained.
Beispiel 4 6-(p-Formylaminophenyl)-4-methyl-4,5-dihydropyridazinon- 3 : 8 g (0,04 Mol) 6-(p-Aminophenyl)-4-methyl-4,5-dihydropyridazinon-3 werden mit 20 ml Ameisensäure 4 Stunden lang zum Sieden erhitzt. Example 4 6- (p-Formylaminophenyl) -4-methyl-4,5-dihydropyridazinone- 3: 8 g (0.04 mol) of 6- (p-aminophenyl) -4-methyl-4,5-dihydropyridazinon-3 are mixed with Heat 20 ml of formic acid to the boil for 4 hours.
Man gießt in 400 ml Wasser, saugt ab, wäscht mit Wasser und trocknet im Vakuum bei 100°C.It is poured into 400 ml of water, filtered off with suction, washed with water and dried in a vacuum at 100 ° C.
AusueuWe; 3,1 g (88 g der Theorie), Rohschmelzpunkt 199 bis 2050C.AusueuWe; 3.1 g (88 g of theory), crude melting point 199-2050C.
Schmelzpunkt nach Umkristallisation aus Dimethylformamld-Wasser 196 bis 200°C.Melting point after recrystallization from dimethylformamide / water 196 up to 200 ° C.
Beispiel 5 6-(p-Aminophenyl)-4-methyl-4,5-dihydropyridazinon- 3 20,7 g (0,1 Mol) 3-(p-Aminobenzoyl)-2-mehylpropionsäure werden in 150 ml Wasser mit 7 g (0,14 Mol) Hydrazinhydrat 4 Stunden lang zum Sieden erhitzt. Man saugt bei OOC ab, wäscht mit Wasser und trocknet bei 1000C im Vakuum Ausbeuteo 18,2 g (89 % der Theorie), Schmelzpunkt aus Dimethylformamid-Wassera 256 bis 2390C. Example 5 6- (p-Aminophenyl) -4-methyl-4,5-dihydropyridazinone-3 20.7 g (0.1 mol) 3- (p-aminobenzoyl) -2-methylpropionic acid are dissolved in 150 ml of water with 7 g (0.14 mol) of hydrazine hydrate heated to boiling for 4 hours. You suck at OOC off, washed with water and dried at 1000C in vacuo Yield 18.2 g (89% der Theory), melting point from dimethylformamide watera 256 to 2390C.
Beispiel 6 6-(p-Aminophenyl)-2,4-dimethyl-4,5-dihydropyridazinono3 0 7,25 g (0,0)5 Mol) 3-(p-Aminobenzoyl)-2-methylpropionsäure werden in 50 ml Wasser mit 1,95 g (0,042 Mol) Methylhydrazin 20 Stunden lang zum Sieden erhitzt Man engt die Lösung zur Trockne ein und kristallisiert den Rückstand aus 30 ml Isopropanol um. Example 6 6- (p-Aminophenyl) -2,4-dimethyl-4,5-dihydropyridazinono3 0 7.25 g (0.0) 5 mol) 3- (p-aminobenzoyl) -2-methylpropionic acid are dissolved in 50 ml of water heated to boiling with 1.95 g (0.042 mol) of methylhydrazine for 20 hours the solution to dryness and the residue crystallized from 30 ml of isopropanol around.
Ausbeute: 4,8 g (65 ß der Theorie); Schmelzpunkt 100 bis 101°C.Yield: 4.8 g (65 μ of theory); Melting point 100 to 101 ° C.
Beispiel 7 6-(p-Äthylaminoacetylaminophenyl)-4-methyl-4,5-dihydropyridazi non- 5 5,6 g (0,02 Mol) 6-(p-Chloracetylaminophenyl)-4-methyl-4,5-di hydropyridazinon-3 werden mit 5,4 g 60 Xiger alkoholischer Athylaminlösung (0,06 Mol) in 50 ml Athanol 2 Stunden auf Siedetemperatur erhitzt. Man engt die Lösung ein, kristallisiert den Rückstand aus 50 ml Wasser um. Example 7 6- (p-Ethylaminoacetylaminophenyl) -4-methyl-4,5-dihydropyridazi non-5 5.6 g (0.02 mole) 6- (p-chloroacetylaminophenyl) -4-methyl-4,5-dihydropyridazinone-3 are with 5.4 g of 60 Xiger alcoholic ethylamine solution (0.06 mol) in 50 ml of ethanol Heated to boiling temperature for 2 hours. The solution is concentrated and the crystallized Residue from 50 ml of water.
Ausbeute: 30,) g Hydrochlorid (99 % der Theorie); Schmelzpunkt 2780C.Yield: 30.) g of hydrochloride (99% of theory); Melting point 2780C.
Beispiel 8 6-(p-N-Methylpiperazinoacetylaminophenyl)-4-methyl-4,5-dihydropyridazinon- 3: 5,6 g (0,02 Mol) 6-(p-Chloracetaminophenyl)-4-methyl-4,5-dihydro pyridazinon-5 werden mit 6 g (0,06 Mol) N-Methylpiperazin in 50 ml Äthanol 2 Stunden lang auf Siedetemperatur erhitzt. Man engt die Lösung ein, schlämmt den Rückstand in Wasser auf, saugt den Niederschlag ab und trocknet im Vakuum bei 800C. Example 8 6- (p-N-Methylpiperazinoacetylaminophenyl) -4-methyl-4,5-dihydropyridazinone- 3: 5.6 g (0.02 mole) 6- (p-chloroacetaminophenyl) -4-methyl-4,5-dihydro pyridazinone-5 are with 6 g (0.06 mol) of N-methylpiperazine in 50 ml of ethanol for 2 hours Boiling temperature heated. The solution is concentrated and the residue is slurried in water up, sucks off the precipitate and dries in vacuo at 80.degree.
Ausbeute: 5,3 g (92 ß der Theorie); Schmelzpunkt aus Dimethylformamid-Wassero 207 bis 209°C.Yield: 5.3 g (92 β of theory); Melting point from dimethylformamide water o 207 to 209 ° C.
Beispiel 9 6-(p-Isopropylaminoacetylaminophenyl)-4-methyl-4,5-dihydropyridazinon-3 : 11,2 g (0,04 Mol) 6-(p-Chloracetaminophenyl)-4-methyl-4,5-dihydro pyridazinon») und 11,8 g (0,2 Mol) Isopropylamin werden in 110 ml Athanol 12 Stunden lang auf Siedetemperatur erhitzt. Man engt die Lösung im Vakuum ein, suspendiert den Rückstand in 100 ml Wasser und stellt mit 2 n-Natronlauge einen pH von 10 ein. Der Rückstand wird abgesaugt, mit Wasser neutral gewaschen und im Vakuum bei 80°C getrocknet. Example 9 6- (p-Isopropylaminoacetylaminophenyl) -4-methyl-4,5-dihydropyridazinone-3 : 11.2 g (0.04 mol) 6- (p-chloroacetaminophenyl) -4-methyl-4,5-dihydro pyridazinone ») and 11.8 g (0.2 mol) of isopropylamine are dissolved in 110 ml of ethanol for 12 hours Boiling temperature heated. The solution is concentrated in vacuo and the residue is suspended in 100 ml of water and adjusts the pH to 10 with 2N sodium hydroxide solution. The residue is filtered off with suction, washed neutral with water and dried in vacuo at 80.degree.
Aus 60 ml Isopropanol erhält man 8,4 g (79 ß der Theorie) vom Schmelzpunkt 1450C.From 60 ml of isopropanol, 8.4 g (79 ß of theory) of the melting point are obtained 1450C.
Beispiel 10 6-(p-sek.-Butylaminoacetylaminophenyl)-4-methyl-4,5-dihydropyri dazinon- )¢ 11,2 g (0,04 Mol) 6-(p-Chloracetaminophenyl)-4-methyl-4,5-dihydropyridazinon-) und 14 g (0,2 Mol) sek.-Butylamin werden in 110 ml Äthanol 12 Stunden am Rückfluß gekocht. Die Lösung wird im Vakuum bei 800C eingeengt. Der Rückstand wird in Wasser aufgeschlämmt und mit 2 n Natronlauge auf pH 10 eingestellt. Man saugt den Rückstand ab, wäscht mit Wasser neutral und trocknet im Vakuum bei 800C. Example 10 6- (p-sec -Butylaminoacetylaminophenyl) -4-methyl-4,5-dihydropyri dazinon-) [11.2 g (0.04 mol) 6- (p-chloroacetaminophenyl) -4-methyl-4,5-dihydropyridazinone-) and 14 g (0.2 mol) of sec-butylamine are refluxed in 110 ml of ethanol for 12 hours cooked. The solution is concentrated in vacuo at 80.degree. The residue is in water Slurried and adjusted to pH 10 with 2N sodium hydroxide solution. The residue is sucked off, washed neutral with water and dried in vacuo at 800C.
Ausbeute: 11,9 g (94 % der Theorie); Schmelzpunkt 106 bis 1070 C.Yield: 11.9 g (94% of theory); Melting point 106 to 1070 C.
Aus 150 ml Isopropanol umkristallisiert erhält man 6,4 g (50 ß der Theorie) vom Schmelzpunkt 112 bis 1150C.Recrystallized from 150 ml of isopropanol, 6.4 g (50 μ of the Theory) from melting point 112 to 1150C.
Beispiel 11 6-(p-Pyrrolidinoacetylaminophenyl)-4-methyl-4,5-dihydropyridazinon-5: 5,6 g-(0,02 Mol) 6-(p-Chloracetaminophenyl)-4-methyl-4,5-dihydropyridazinon-3 und 4,5 g (0,06 Mol) Pyrrolidin werden in 50 ml Äthanol 2 Stunden bei Siedetemperatur erhitzt. Man engt die Lösung ein, nimmt mit Wasser auf, saugt den Niederschlag ab, wäscht mit Wasser nach und trocknet im Vakuum bei 800C. Example 11 6- (p-Pyrrolidinoacetylaminophenyl) -4-methyl-4,5-dihydropyridazinone-5: 5.6 g- (0.02 mol) 6- (p-chloroacetaminophenyl) -4-methyl-4,5-dihydropyridazinone-3 and 4.5 g (0.06 mol) of pyrrolidine are in 50 ml Ethanol for 2 hours Boiling temperature heated. The solution is concentrated, taken up with water, then sucked up Precipitate is washed off with water and dried in vacuo at 80.degree.
Ausbeute: 5,7 g (90 % der Theorie); Schmelzpunkt 185 bis 1850C.Yield: 5.7 g (90% of theory); Melting point 185 to 1850C.
Claims (12)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19732304977 DE2304977A1 (en) | 1973-02-01 | 1973-02-01 | 3-Aminoaryl-5-alkyl-4,5-dihydro-6(1H)-pyridazones - prepd. by reacting 2-alkyl-3-aminoaroyl-propionic acids with hydrazines |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19732304977 DE2304977A1 (en) | 1973-02-01 | 1973-02-01 | 3-Aminoaryl-5-alkyl-4,5-dihydro-6(1H)-pyridazones - prepd. by reacting 2-alkyl-3-aminoaroyl-propionic acids with hydrazines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2304977A1 true DE2304977A1 (en) | 1974-08-08 |
Family
ID=5870665
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19732304977 Withdrawn DE2304977A1 (en) | 1973-02-01 | 1973-02-01 | 3-Aminoaryl-5-alkyl-4,5-dihydro-6(1H)-pyridazones - prepd. by reacting 2-alkyl-3-aminoaroyl-propionic acids with hydrazines |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE2304977A1 (en) |
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0000113A1 (en) * | 1977-06-18 | 1979-01-10 | BASF Aktiengesellschaft | Dihydropyridazones, their preparation and medicines containing them and dihydropyridazones for use in medical treatments |
| EP0089528A1 (en) * | 1982-03-13 | 1983-09-28 | BASF Aktiengesellschaft | 6-Aryl-4,5-dihydro-3(2H)-pyridazinones, their preparation and use |
| US4410529A (en) | 1980-06-13 | 1983-10-18 | Basf Aktiengesellschaft | Novel dihydropyridazinones, their preparation and therapeutic agents containing these compounds |
| US4415571A (en) | 1980-06-13 | 1983-11-15 | Basf Aktiengesellschaft | Carbamate dihydropyridazinones, their preparation and therapeutic agents containing these compounds |
| FR2528837A1 (en) * | 1982-06-18 | 1983-12-23 | Therapeutique Applic Sa | ARYLACETYL BUTANOLIDES AND THEIR PYRIDAZINONE DERIVATIVES AS MEDICAMENTS, AND METHODS FOR THEIR MANUFACTURE |
| EP0117403A1 (en) * | 1983-01-22 | 1984-09-05 | BASF Aktiengesellschaft | 6-(Acylaminoaryl)-3(2H)-pyridazinone derivatives, their preparation and use |
| US4474785A (en) * | 1981-06-24 | 1984-10-02 | Basf Aktiengesellschaft | 2-Aryl-3,4-diazabicyclo[4.n.O]alk-2-en-5-ones, and compositions for treating thermo-embolic disorders |
| US4639451A (en) * | 1981-10-20 | 1987-01-27 | Mitsui Toatsu Kagaku-Kabushiki Kaisha | Pyridazinone derivatives |
| EP0231744A1 (en) * | 1986-01-08 | 1987-08-12 | BASF Aktiengesellschaft | Substituted pyrrol-1-ylphenyldihydropyridazinones, their preparation and use |
| WO2018086703A1 (en) | 2016-11-11 | 2018-05-17 | Bayer Pharma Aktiengesellschaft | Dihydropyridazinones substituted with phenylureas |
| WO2019149637A1 (en) | 2018-01-31 | 2019-08-08 | Bayer Aktiengesellschaft | Antibody drug conjugates (adcs) with nampt inhibitors |
| WO2021013693A1 (en) | 2019-07-23 | 2021-01-28 | Bayer Pharma Aktiengesellschaft | Antibody drug conjugates (adcs) with nampt inhibitors |
-
1973
- 1973-02-01 DE DE19732304977 patent/DE2304977A1/en not_active Withdrawn
Cited By (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0000113A1 (en) * | 1977-06-18 | 1979-01-10 | BASF Aktiengesellschaft | Dihydropyridazones, their preparation and medicines containing them and dihydropyridazones for use in medical treatments |
| US4415571A (en) | 1980-06-13 | 1983-11-15 | Basf Aktiengesellschaft | Carbamate dihydropyridazinones, their preparation and therapeutic agents containing these compounds |
| US4410529A (en) | 1980-06-13 | 1983-10-18 | Basf Aktiengesellschaft | Novel dihydropyridazinones, their preparation and therapeutic agents containing these compounds |
| US4474785A (en) * | 1981-06-24 | 1984-10-02 | Basf Aktiengesellschaft | 2-Aryl-3,4-diazabicyclo[4.n.O]alk-2-en-5-ones, and compositions for treating thermo-embolic disorders |
| US4639451A (en) * | 1981-10-20 | 1987-01-27 | Mitsui Toatsu Kagaku-Kabushiki Kaisha | Pyridazinone derivatives |
| US4965263A (en) * | 1981-10-20 | 1990-10-23 | Mitsui Toatsu Kagaku Kabushiki Kaisha | 6-acylaminophenyl-5-alkyl-4,5-dihydro-3(2H)-pyridazinone compounds useful as blood pressure depressants, antithrombotic agents and in the treatment of heart disease |
| EP0089528A1 (en) * | 1982-03-13 | 1983-09-28 | BASF Aktiengesellschaft | 6-Aryl-4,5-dihydro-3(2H)-pyridazinones, their preparation and use |
| US4544562A (en) * | 1982-03-13 | 1985-10-01 | Basf Aktiengesellschaft | 6-Aryl-4,5-dihydro-3(2H)-pyridazinones, and their use as anti-hypertensive and anti-thrombocyte agents |
| FR2528837A1 (en) * | 1982-06-18 | 1983-12-23 | Therapeutique Applic Sa | ARYLACETYL BUTANOLIDES AND THEIR PYRIDAZINONE DERIVATIVES AS MEDICAMENTS, AND METHODS FOR THEIR MANUFACTURE |
| EP0117403A1 (en) * | 1983-01-22 | 1984-09-05 | BASF Aktiengesellschaft | 6-(Acylaminoaryl)-3(2H)-pyridazinone derivatives, their preparation and use |
| USRE33476E (en) * | 1983-01-22 | 1990-12-04 | Basf Akteingesellschaft | 6-(alkanolaminoaryl)-3(2H)-pyridazinone derivatives, and their use |
| EP0231744A1 (en) * | 1986-01-08 | 1987-08-12 | BASF Aktiengesellschaft | Substituted pyrrol-1-ylphenyldihydropyridazinones, their preparation and use |
| WO2018086703A1 (en) | 2016-11-11 | 2018-05-17 | Bayer Pharma Aktiengesellschaft | Dihydropyridazinones substituted with phenylureas |
| WO2019149637A1 (en) | 2018-01-31 | 2019-08-08 | Bayer Aktiengesellschaft | Antibody drug conjugates (adcs) with nampt inhibitors |
| WO2021013693A1 (en) | 2019-07-23 | 2021-01-28 | Bayer Pharma Aktiengesellschaft | Antibody drug conjugates (adcs) with nampt inhibitors |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0042592B1 (en) | N-heteroarylalkylene diamines, process for their preparation and their use | |
| EP0006506B1 (en) | Carbostyrile derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| DE3784401T2 (en) | CARBOSTYRILE DERIVATIVES AND THEIR SALTS, METHOD FOR THE PRODUCTION THEREOF AND THE CARDIOTONIC COMPOSITION CONTAINING THEM. | |
| DE3132882A1 (en) | NEW PIPERAZINONE, THEIR PRODUCTION AND USE | |
| DE2304977A1 (en) | 3-Aminoaryl-5-alkyl-4,5-dihydro-6(1H)-pyridazones - prepd. by reacting 2-alkyl-3-aminoaroyl-propionic acids with hydrazines | |
| EP0090978B1 (en) | Imidazolylphenyl-tetrahydropyridazines, process for their preparation and pharmaceutical compositions containing them | |
| DE2926517A1 (en) | SUBSTITUTED 3-ARYL-PYRAZOLE AND 5-ARYL-ISOXAZOLE AND METHOD FOR THE PRODUCTION THEREOF | |
| DE1620035A1 (en) | 3-Amino-5-X-6-halopyrazinonitriles and process for their preparation | |
| CH638202A5 (en) | 3- (PYRAZOL-1-YL) -PYRIDAZINE DERIVATIVES, THE SALTS THEREOF AND METHOD FOR THE PRODUCTION THEREOF. | |
| EP0000220A1 (en) | Dihydrouracils, process for their preparation and pharmaceuticals containing them | |
| DE2446821A1 (en) | SUBSTITUTED 1,3-DIMETHYL-1HPYRAZOLE SQUARE BRACKET TO 3.4B SQUARE BRACKET FOR -CHINOLINE | |
| DE2427943C2 (en) | Benzimidazoles, processes for their preparation and pharmaceuticals containing them | |
| DE3586324T2 (en) | TETRAHYDROPHTHALIMIDE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE. | |
| CH597199A5 (en) | 3-Phenyl pyridaz-6-ones prodn. | |
| CH638516A5 (en) | Process for preparing substituted aminoquinazoline derivatives | |
| EP0331093A1 (en) | Benzimidazo[1,2-c]quinazolines, their preparation and use | |
| DE2114884A1 (en) | Basically substituted derivatives of 1 (2H) -phthalazinone | |
| DE2819896A1 (en) | CHROME DERIVATIVES, METHOD FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THE SAME | |
| CH681300A5 (en) | ||
| DE4239540A1 (en) | New heterocyclic compounds with anti-asthmatic / anti-allergic, anti-inflammatory, positive inotropic and hypotensive effects | |
| AT230888B (en) | Process for the preparation of new hydrazine derivatives | |
| DE848818C (en) | Process for the preparation of new hydrazine compounds and their derivatives | |
| AT317867B (en) | Process for the preparation of new 3-amidino-2,4,6-triiodobenzamides | |
| AT250338B (en) | Process for the preparation of new, basic derivatives of substituted benzofuran-2-carboxylic acids and their salts | |
| AT326129B (en) | PROCESS FOR THE PRODUCTION OF QUINAZOLINE-2-ON COMPOUNDS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OD | Request for examination | ||
| 8130 | Withdrawal |